According to the NIH, more than 6 million Americans are living with Alzheimer’s disease. Recent studies suggest that somewhere between 50 and 80% of patients aren’t diagnosed with this ailment because of inefficient procedures that are related to the traditional diagnosis methods. In the past two years, screening for Alzheimer’s has become even trickier due to the COVID-19 pandemic and the fact that a huge percentage of people with symptoms aren’t able to arrange an appointment.
Traditional methods are also directly related to time inefficiency and high prices. On average, an American citizen pays over $5000 for a single Alzheimer’s treatment. Furthermore, the traditional diagnosis takes more than 5 hours, and you may have to wait for the results for weeks if not even months. With that in mind, it doesn’t come as a surprise that a 2021 survey showed that 90% of elderly people were interested in remote screening and non-invasive testing.
Issues Related to the Traditional Screening
In the past couple of years, researchers have shown that over 50–80% of people are yet to be diagnosed with Alzheimer’s disease. The main issue? The fact that the traditional methods are hindered due to the COVID-19 pandemic, as well as the fact that the cost of the procedure is pretty expensive, There are many issues related to this, as potential patients who can’t undergo screening stand at a greater risk of developing dementia as well as cognitive impairment.
According to numerous studies, including the FINGER study from 2019, as well as the study conducted by Livingston in 2020, on-time detection and preventive measures make a huge difference. Thus, making remote screening and non-invasive testing more popular could lower cognitive impairment by 30% and reduce the chances of mild dementia by up to 40%.
Additionally, remote screening diagnoses are commonly put in context with affordable pricing and time efficiency. With that in mind, apps such as ADix can make a huge difference in the upcoming years.
Why Is Remote Screening Revolutionizing?
Apart from the fact that thousands of people with Alzheimer’s symptoms aren’t able to visit their local hospital or afford a diagnostic procedure of $5000, remote screening is of utmost importance not only for the patients but for doctors as well. For example, a neurologist will be able to prescribe treatment and preventive measures on time, and without spending weeks analyzing the symptoms.
Not only that but remote screening allows that more patients are tested at the same time. As of today, the best solution for the inefficiency of traditional in-hospital diagnoses seems to be smartphone apps such as CognSolutiones. This cost-efficient software combines cognitive assessment with the detection of relevant facial features to diagnose Alzheimer’s disease and suggest preventive measures.
Furthermore, the fact that it can be installed on a smartphone or a tablet makes it an ideal choice for people who are on the go or aren’t able to visit a hospital. Contrary to in-hospital screening, ADix is time-efficient and analyzes Alzheimer’s symptoms within minutes.
Popular Forms of Remote Screening for Alzheimer’s Disease
Because MRI scans aren’t portable, it is almost impossible to get a traditional diagnosis for Alzheimer’s disease outside of a competent hospital. With that in mind, a sophisticated smartphone app seems to be the exclusive solution.
While there are skeptics who question the efficiency of the featured AI engine, pilot studies such as those performed in 2020 showed that Cognes is incredibly accurate and delivers results in 90% less time than traditional methods. Plus, remote screening is available to anyone who experiences symptoms of Alzheimer’s disease or simply wants to perform a regular check-up and take preventive measures.
How Remote Screening Works?
As a leader in remote screening for Alzheimer’s disease, Cognes comes with a user-friendly interface and an AI-powered engine. To ensure accurate results, it combines the detection of relevant facial features with the answers that you give to the cognitive assessment questions. The finest point about Cognes is that you can test yourself for Alzheimer’s disease in the comfort of your home. All it will take is a couple of minutes of your time.
On the other hand, the advantages are enormous. The app can either detect that you don’t have symptoms of Alzheimer’s disease or that you have developed the condition. In the second scenario, you will probably stand at a great advantage compared to the traditional diagnoses given the fact that you will be able to take suggested measures to prevent dementia, cognitive impairment, and other Alzheimer-related ailments.
Can You Trust the AI Engine?
The programmers at Cognes did a fantastic job developing software that uses an AI engine to scan facial features the same way that an MRI does. It is an innovative technology that wasn’t available until two years ago. The sophisticated computer vision is responsible for analyzing changes in the cerebral blood flow, which can point to Alzheimer’s disease.
Not only that but there are a wide variety of medical studies that suggest there are facial expressions relevant to Alzheimer’s disease. Once again, computer vision tracks your facial movements for the few minutes of the test, putting them in context with the ailments. Last but certainly not least, certain facial features may indicate that you have inherited Alzheimer’s disease (which starts to appear up to 15 years old before detection).
Remote screening for Alzheimer’s disease was never as important. COVID-19, as well as the fact that the majority of the population can’t afford to spend $5000-$10000 on the diagnosis of Alzheimer’s disease, suggest that remote screening is a necessity. The machine-learning-based smartphone app offers time-efficient diagnosis by analyzing cerebral and facial features and going through the answers to the relevant cognitive assessment tests.
Hence, the remote screening Cognes stands as an effective alternative to the traditional methods, which require that you visit a hospital and pay thousands of dollars to get the results a few weeks or months later.